1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. OVID THERAPEUTICS INC
Ovid Therapeutics Inc
XNAS: OVID
2.76 0.05 (1.85%)
3.7M

XNAS 22 Sep, 2026 4:04 PM (EDT)

Watchlist

Portfolio

Alert

Ovid Therapeutics Inc - OVID - stock price prediction, stock price target, analyst ratings from 10 analysts

Ovid Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -88.7%, and profit growth estimate of -292.4% for FY26, based on top 10 analyst calls.